Why Shares of Surmodics Jumped This Week
The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries.
Why Shares of Surmodics Soared on Tuesday
An analyst upgrade gave the stock a boost.
Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March...